Literature DB >> 16618715

Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression.

Maranke I Koster1, Shi-Long Lu, Lisa D White, Xiao-Jing Wang, Dennis R Roop.   

Abstract

Genes that are active during normal development are frequently reactivated during neoplastic transformation. We now report that developmentally expressed TAp63 isoforms are frequently reactivated in human squamous cell carcinomas. To determine the consequences of TAp63 reactivation, we induced TAp63alpha expression during chemically-induced skin carcinogenesis. Deregulated TAp63alpha expression dramatically accelerated tumor development and progression, frequently resulting in epithelial-mesenchymal transitions to spindle cell carcinomas and lung metastases. Consistent with this observation, we detected high levels of Twist and N-cadherin in tumors overexpressing TAp63alpha. Thus, as observed for other developmental pathways, aberrant reactivation of TAp63 predisposes to tumor development and progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618715     DOI: 10.1158/0008-5472.CAN-06-0027

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

2.  DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma.

Authors:  Karine Pallier; Aurélie Cazes; Laila El Khattabi; Cristina Lecchi; Marine Desroches; Claire Danel; Marc Riquet; Elizabeth Fabre-Guillevin; Pierre Laurent-Puig; Hélène Blons
Journal:  Tumour Biol       Date:  2011-10-11

3.  The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.

Authors:  Kathryn E King; Roshini M Ponnamperuma; Clint Allen; Hai Lu; Praveen Duggal; Zhong Chen; Carter Van Waes; Wendy C Weinberg
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

4.  Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.

Authors:  Yoshitsugu Mitani; Jie Li; Randal S Weber; Scott L Lippman; Elsa R Flores; Carlos Caulin; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.

Authors:  Marta Nekulova; Jitka Holcakova; Rudolf Nenutil; Rembert Stratmann; Pavla Bouchalova; Petr Müller; Lucie Mouková; Philip J Coates; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2013-07-26       Impact factor: 4.064

6.  Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma.

Authors:  Michael Herfs; Pascale Hubert; Meggy Suarez-Carmona; Anca Reschner; Sven Saussez; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

7.  TAp63 is a transcriptional target of NF-kappaB.

Authors:  Junfeng Wu; Johann Bergholz; Jinin Lu; Gail E Sonenshein; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

8.  TATA-binding Protein (TBP)-like Protein Is Engaged in Etoposide-induced Apoptosis through Transcriptional Activation of Human TAp63 Gene.

Authors:  Yusuke Suenaga; Toshinori Ozaki; Yuji Tanaka; Youquan Bu; Takehiko Kamijo; Takeshi Tokuhisa; Akira Nakagawara; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 9.  Lessons from development: A role for asymmetric stem cell division in cancer.

Authors:  Anne E Powell; Chia-Yi Shung; Katherine W Saylor; Karin A Müllendorff; Karin A Müllendorf; Joseph B Weiss; Melissa H Wong
Journal:  Stem Cell Res       Date:  2009-09-25       Impact factor: 2.020

10.  p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.

Authors:  Philip J Coates; Rudolf Nenutil; Jitka Holcakova; Marta Nekulova; Jan Podhorec; Marek Svoboda; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2018-02-27       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.